Amgen invests additional $300m to strengthen biomanufacturing in Puerto Rico

2026-05-06T11:08:00

Juncos Puerto Rico flag

Source:

Expansion brings firm’s total US manufacturing commitment over the last year to nearly $2 billion.

Amgen is directing an additional $300 million in its US manufacturing operations in Juncos, Puerto Rico, to boost production capacity and enhance next-generation technologies.

Robert Bradway, Chairman and Chief Executive Officer, Amgen, said the investment will

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

  • Unlimited access to industry intelligence that can make a difference to your business
  • A weekly newsletter keeping the most vital information at the front of your thinking
  • Exclusive invitations to powerful webinars and events featuring high profile experts
  • Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member